<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03736304</url>
  </required_header>
  <id_info>
    <org_study_id>2018-SR-180</org_study_id>
    <nct_id>NCT03736304</nct_id>
  </id_info>
  <brief_title>The Effect of Automated Electronic Alert for Acute Kidney Injury on the Outcomes of Hospitalized Patients</brief_title>
  <official_title>The Effect of Automated Electronic Alert for Acute Kidney Injury on the Outcomes of Hospitalized Patients: a Single Center Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Affiliated Hospital with Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The First Affiliated Hospital with Nanjing Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute kidney injury (AKI) is a common disease, but diagnosis is usually delayed or missed in
      hospitalized patients. The automated electronic alert for AKI may help to improve the
      outcomes of these patients through identifying all cases of AKI early. Therefore, the
      investigators conduct a randomly controlled study to test whether automated electronic alert
      for AKI could improve the outcomes of hospitalized patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute kidney injury (AKI) is a common disease, but diagnosis is usually delayed or missed in
      hospitalized patients. The automated electronic alert for AKI may help to improve the
      outcomes of these patients through identifying all cases of AKI early. Therefore, the
      investigators conduct a randomly controlled study to test whether automated electronic alert
      for AKI could improve the outcomes of hospitalized patients.

      The patients were randomly divided into two groups:

      Usual care : patients will receive standard clinical care by the primary physicians AKI alert
      : an AKI alert will be sent to the doctor in charge. The team of kidney experts would give a
      suggestion if the doctor in charge need a renal consultation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Estimated glomerular filtration rate changed within 7 days</measure>
    <time_frame>within 7 days diagnosed with AKI</time_frame>
    <description>Medical record</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>seven-day mortality</measure>
    <time_frame>within 7 days diagnosed with AKI</time_frame>
    <description>Medical record</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30-day mortality</measure>
    <time_frame>within 30 days diagnosed with AKI</time_frame>
    <description>Medical record</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1-year mortality</measure>
    <time_frame>within 1 year diagnosed with AKI</time_frame>
    <description>telephone follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>receiving renal replacement therapy at seventh day</measure>
    <time_frame>7 days</time_frame>
    <description>Medical record</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>receiving renal replacement therapy at 30th day</measure>
    <time_frame>30 days</time_frame>
    <description>telephone follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>receiving renal replacement therapy at 1 year</measure>
    <time_frame>1 year</time_frame>
    <description>telephone follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the rate of stage 2 AKI</measure>
    <time_frame>within 7 days diagnosed with AKI</time_frame>
    <description>Medical record</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the rate of stage 3 AKI</measure>
    <time_frame>within 7 days diagnosed with AKI</time_frame>
    <description>Medical record</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the rate of AKI recovery at 90 day</measure>
    <time_frame>90 days</time_frame>
    <description>telephone follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the rate of timely-recognition of AKI</measure>
    <time_frame>3 days</time_frame>
    <description>Medical record</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the interventions for AKI</measure>
    <time_frame>within 7 days diagnosed with AKI</time_frame>
    <description>Medical record</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Follow-up rate after discharge</measure>
    <time_frame>1 year</time_frame>
    <description>telephone follow-up</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Acute Kidney Injury</condition>
  <condition>Outcomes</condition>
  <condition>Early Diagnosis</condition>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive standard clinical care by the doctor in charge.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AKI alert</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>An AKI alert will send to the the doctor in charge. The team of nephrologists would give suggestions if the doctor in charge need a renal consultation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AKI alert</intervention_name>
    <description>An AKI alert will send to the doctor in charge. The team of nephrologists would give suggestions if the doctor in charge need a renal consultation.</description>
    <arm_group_label>AKI alert</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual care</intervention_name>
    <description>Patients will receive standard clinical care by the doctor in charge.</description>
    <arm_group_label>Usual care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hospitalized adult patients with an Alert for AKI(based on KDIGO guidelines)

        Exclusion Criteria:

          -  Patients already having eGFR&lt;15ml/min/1.73m2 or receiving renal replacement therapy
             for AKI at the time of alert.

          -  Patients already having a AKI before admission.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Huijuan Mao, PhD,MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Nephrology, The First Affiliated Hospital of Nanjing Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Huijuan Mao, PhD,MD</last_name>
    <phone>86-13851746819</phone>
    <phone_ext>8613851746819</phone_ext>
    <email>huijuanmao@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Huijuan Mao, PhD,MD</last_name>
    <phone>8613851746819</phone>
    <phone_ext>8613851746819</phone_ext>
    <email>huijuanmao@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Jiangsu Province Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Buyun Wu, MD</last_name>
      <phone>8615950594895</phone>
      <phone_ext>8615950594895</phone_ext>
      <email>wubuyun@njmu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Huijuan Mao, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Buyun Wu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Wu B, Li L, Cheng X, Yan W, Liu Y, Xing C, Mao H. Propensity-score-matched evaluation of under-recognition of acute kidney injury and short-term outcomes. Sci Rep. 2018 Oct 11;8(1):15171. doi: 10.1038/s41598-018-33103-9.</citation>
    <PMID>30310097</PMID>
  </reference>
  <reference>
    <citation>Yang L, Xing G, Wang L, Wu Y, Li S, Xu G, He Q, Chen J, Chen M, Liu X, Zhu Z, Yang L, Lian X, Ding F, Li Y, Wang H, Wang J, Wang R, Mei C, Xu J, Li R, Cao J, Zhang L, Wang Y, Xu J, Bao B, Liu B, Chen H, Li S, Zha Y, Luo Q, Chen D, Shen Y, Liao Y, Zhang Z, Wang X, Zhang K, Liu L, Mao P, Guo C, Li J, Wang Z, Bai S, Shi S, Wang Y, Wang J, Liu Z, Wang F, Huang D, Wang S, Ge S, Shen Q, Zhang P, Wu L, Pan M, Zou X, Zhu P, Zhao J, Zhou M, Yang L, Hu W, Wang J, Liu B, Zhang T, Han J, Wen T, Zhao M, Wang H; ISN AKF 0by25 China Consortiums. Acute kidney injury in China: a cross-sectional survey. Lancet. 2015 Oct 10;386(10002):1465-71. doi: 10.1016/S0140-6736(15)00344-X.</citation>
    <PMID>26466051</PMID>
  </reference>
  <reference>
    <citation>Wilson FP, Shashaty M, Testani J, Aqeel I, Borovskiy Y, Ellenberg SS, Feldman HI, Fernandez H, Gitelman Y, Lin J, Negoianu D, Parikh CR, Reese PP, Urbani R, Fuchs B. Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial. Lancet. 2015 May 16;385(9981):1966-74. doi: 10.1016/S0140-6736(15)60266-5. Epub 2015 Feb 26.</citation>
    <PMID>25726515</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>November 8, 2018</study_first_submitted>
  <study_first_submitted_qc>November 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2018</study_first_posted>
  <last_update_submitted>February 6, 2020</last_update_submitted>
  <last_update_submitted_qc>February 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

